W H Fridman Selected Research

W H Fridman Research Topics

Disease

12	Neoplasms (Cancer) 01/2014 - 01/2000
3	Carcinoma (Carcinomatosis) 02/2011 - 11/2001
3	Infections 03/2005 - 03/2000
2	Head and Neck Neoplasms (Head and Neck Cancer) 10/2007 - 04/2001
2	Medullary Carcinoma 01/2003 - 01/2000
2	Necrosis 09/2001 - 01/2000
2	Crohn Disease (Crohn's Disease) 03/2001 - 12/2000
2	Inflammation (Inflammations) 01/2001 - 12/2000
1	Tertiary Lymphoid Structures 01/2022
1	Sarcoma (Soft Tissue Sarcoma) 01/2022
1	Osteosarcoma (Osteogenic Sarcoma) 01/2019
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2018
1	Human Influenza (Influenza) 04/2012
1	Hypoxia (Hypoxemia) 03/2011
1	Atypical Hemolytic Uremic Syndrome 08/2008
1	Thrombotic Microangiopathies 08/2008
1	Protein Deficiency 03/2005
1	Complement Component 7 Deficiency 03/2005
1	Breast Neoplasms (Breast Cancer) 01/2003
1	Autoimmune Diseases (Autoimmune Disease) 01/2001
1	Melanoma (Melanoma, Malignant) 12/2000
1	Colonic Neoplasms (Colon Cancer) 12/2000
1	Neoplasm Metastasis (Metastasis) 12/2000
1	Mastocytoma 09/2000

Drug/Important Bio-Agent (IBA)

6	CytokinesIBA 03/2011 - 01/2000
4	Proteins (Proteins, Gene)FDA Link 08/2008 - 12/2000
3	Complement System Proteins (Complement)IBA 08/2008 - 03/2001
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2001 - 01/2000
3	Interleukin-18 (Interleukin 18)IBA 03/2001 - 03/2000
2	pembrolizumabIBA 01/2022 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 01/2014 - 04/2001
2	AntigensIBA 04/2012 - 09/2000
2	Interleukin-2 Receptors (IL 2 Receptor)IBA 10/2007 - 04/2001
2	Immunoglobulins (Immunoglobulin)IBA 01/2003 - 01/2000
2	Peptides (Polypeptides)IBA 01/2003 - 09/2000
2	AntibodiesIBA 01/2003 - 11/2001
2	LigandsIBA 11/2001 - 03/2001
2	IgG Receptors (Fc gamma RI)IBA 03/2001 - 12/2000
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019
1	Lenalidomide (CC 5013)FDA Link 01/2018
1	Thimerosal (Thiomersal)IBA 04/2012
1	VaccinesIBA 04/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2011
1	Cancer VaccinesIBA 02/2011
1	TG4010IBA 02/2011
1	Membrane Cofactor ProteinIBA 08/2008
1	chemotactic factor inactivatorIBA 08/2008
1	Interleukin-2 Receptor alpha SubunitIBA 10/2007
1	ProperdinIBA 03/2005
1	Interleukin-4 (Interleukin 4)IBA 03/2003
1	Interleukin-17 (Interleukin 17)IBA 03/2003
1	Messenger RNA (mRNA)IBA 03/2003
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2003
1	Immunoglobulin Variable RegionIBA 01/2003
1	Liposomes (Liposome)IBA 12/2002
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 12/2002
1	KIR ReceptorsIBA 11/2001
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 11/2001
1	Bispecific AntibodiesIBA 11/2001
1	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 11/2001
1	Interleukin-2 (IL2)IBA 11/2001
1	EnzymesIBA 09/2001
1	ImmunosorbentsIBA 09/2001
1	IceIBA 03/2001
1	Caspase 1 (ICE Protease)IBA 03/2001
1	Chemokine CCL5IBA 03/2001
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2001
1	Tyrosine (L-Tyrosine)FDA Link 12/2000
1	ClathrinIBA 12/2000
1	Fc gamma receptor IIAIBA 12/2000
1	Shiga Toxin (Shigella Toxin)IBA 09/2000
1	Recombinant ProteinsIBA 09/2000
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2000
1	Interferon-gamma (Interferon, gamma)IBA 01/2000
1	Interleukin-12 (IL 12)IBA 01/2000

Therapy/Procedure

4	Immunotherapy 01/2019 - 03/2003
1	Therapeutics 03/2011
1	Kidney Transplantation 08/2008